The Lancet Examines Congressional Support For U.S. Cures Act, Potential For Funding

The Lancet: Experts confident of Congressional funding for U.S. Cures Act
“Just five weeks before his presidency ended, Barack Obama signed the 21st Century Cures Act, a law that will sustain several of his signature biomedical research initiatives, streamline the U.S. drug and medical device approval process, improve the nation’s mental health care system, and combat the country’s opioid misuse epidemic. The legislation won nearly unanimous approval in both houses of Congress … But the funding to implement the law is not guaranteed…” (Jaffe, 1/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.